Two clinical studies found that controlled mango intake (Safeda, Dasheri, Langra) produced similar or lower glycemic responses than bread, reduced glycemic variability, and improved glucose, insulin resistance, weight, and lipid profile in people with type 2 diabetes. These benefits were observed when mangoes replaced other carbohydrates in the diet under medical supervision.